#TripleGivingTuesdayOMF is an exciting opportunity to triple your impact and accelerate groundbreaking biomedical research into Myalgic Encephalomyelitis (ME/CFS) and related chronic, complex related diseases. Every donation made to OMF any day of the week between Oct 19 through Nov 30, 2021 will be triple matched. Regardless of how you donate, when you donate, or where you donate, your gift will be TRIPLED! That means $10 equals $30, $20 equals $60, and so on! There’s no better time than Triple Giving Tuesday to support research — don’t miss out.
Create a Triple Giving Tuesday fundraiser for OMF starting October 19 and ending November 30, 2021! (You can set the goal for any amount you choose, and be sure to let your donors know: All donations received within this time frame will be TRIPLED!)
Be featured by OMF in a blog post or newsletter for our website and social media! Answer the following prompt and email your response to firstname.lastname@example.org:
Triple Giving Tuesday means you have THREE TIMES the impact on ME/CFS research. What are three reasons you are supporting OMF’s 2021 Triple Giving Tuesday campaign?
Repost our social media posts about Triple Giving Tuesday on your own social media accounts. Don’t forget to tag us!
Copy and paste the text below to post on social media so you can tell your friends and family about OMF, and why supporting Triple Giving Tuesday matters to you.
Social Media Post for Facebook or Instagram:
As some of you know, I have Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS). I’m excited to share that Open Medicine Foundation (OMF) is kicking off its annual #TripleGivingTuesdayOMF campaign today! Thanks to generous matching donors, every dollar you donate to OMF any day of the week will be triple matched now through International Giving Tuesday on November 30, 2021!
Why is this important? ME / CFS is a devastating, life-altering, multi-system disease affecting up to 2.5 million Americans (or 20 million people worldwide), and many more may become afflicted in the aftermath of COVID-19.
While its impact is widespread and devastating, relatively little is known about the disease, no FDA-approved treatments exist, and patients are left to deal with the illness with little help from the medical establishment, in many cases for decades.
Fortunately, OMF is working to change the research landscape. OMF is a US-based global nonprofit, with a 19-member Scientific Advisory Board that includes two Nobel laureates and six National Academy of Sciences members. OMF has facilitated and funded the establishment of five research centers across the globe dedicated to diagnosing, treating, and ultimately preventing these related chronic, complex diseases.
OMF is leading the research and making real headway. There is now a committed community of world-renowned scientists, doctors, and patients raising awareness and making great strides in finding treatments that bring ME / CFS patients some relief and hope for a normal life in the future.
When you donate, you help to accelerate this critical research, giving hope to millions.
Please join me by supporting #TripleGivingTuesdayOMF today. Or you can visit OMF’s website to discover a donation option that’s best for you.
Thank you for your support
Social Media Post for Twitter:
Thanks to matching donors, every dollar you donate to @OpenMedF any day of the week will be TRIPLE MATCHED now through International Giving Tuesday on November 30, 2021! Please join me in accelerating research of #MECFS & related diseases by donating: OMF.ngo/TripleTuesday2021
Post on your own social media page and be sure to tag Open Medicine Foundation!
Video Transcript Example:
“Hello, my name is (x) (Briefly describe who you are, and why you support our mission.)
I’m excited to share that Open Medicine Foundation is kicking off their annual #TripleGivingTuesdayOMF campaign today! Thanks to generous matching donors, every dollar you donate to OMF any day of the week will be triple matched now through International Giving Tuesday on November 30, 2021!
Why is this important? ME / CFS is a devastating multi-system disease affecting up to 20 million people worldwide, and many more may become afflicted in the aftermath of COVID-19.
While its impact is widespread, relatively little is known about the disease, and no FDA-approved treatments exist. Patients are left to deal with the illness with little help from the medical establishment, in many cases for decades.
Fortunately, OMF is working to change the research landscape. They have facilitated and funded the establishment of six research centers across the globe dedicated to diagnosing, treating, and ultimately preventing chronic, complex diseases. There’s no better time to donate and accelerate OMF’s work than Triple Giving Tuesday.
Please join me by donating today! You can visit omf.ngo to make a donation or create your own fundraiser. Thank you for your support! Together, we can end ME/CFS.”
Want to educate your personal community more about ME/CFS and related diseases? Check out our Social Shareables page to download informational graphics to post on social media! or click through the image slider below to download:
Gifting of Stock
DTC #: 0164
Account #: 47083887
Account Registered as:
Open Medicine Foundation
29302 Laro Drive
Agoura Hills, CA 91301
Please speak to your personal tax advisor and then call OMF at 650-242-8669 to notify us of your donation or with any questions.
Averting a second pandemic:
Open Medicine Foundation leads groundbreaking international study of
Long COVID’s conversion to ME/CFS
AGOURA HILLS, CALIF. — Open Medicine Foundation (OMF) is leading a large-scale international collaborative study investigating the potential conversion of Post-Acute Sequelae SARS-CoV-2 infection — more commonly known as Long COVID or Post-COVID Syndrome — to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a chronic, life-altering disease with no known cause, diagnostic test or FDA approved treatments available.
Up to 2.5 million people in the U.S. alone suffer from ME/CFS; the COVID-19 pandemic could at least double that number. An estimated 35 percent of Americans who had COVID-19 have failed to fully recover several months after infection, prompting many to call it “a potential second pandemic.”
OMF recognized a familiar health crisis emerging, one with eerie similarities to ME/CFS. This crisis presented a unique opportunity to understand how a viral infection — in this case COVID-19 — may develop into ME/CFS in some patients. The goal is to find targeted treatments for ME/CFS patients and ultimately prevent its onset in people infected with SARS-CoV-2 or other infections.
The federal government is only now investing in Post-COVID research, with no focus on its connection to ME/CFS. OMF has already engaged researchers for the largest-scale study of its kind, solely supported by private donors who have contributed over one million dollars to date. When fully funded, the five million dollar, three-year study will be conducted across the globe at OMF funded Collaborative Research Centers, led by some of the world’s top researchers and ME/CFS experts.
In a significant percentage of patients, infections preceded their development of ME/CFS. For example, according to the CDC about one in ten infected with Epstein-Barr virus, Ross River virus, or Coxiella burnetti develop symptoms that meet the criteria for ME/CFS.
The ability to follow the development of ME/CFS from a known viral infection is unprecedented to date and crucial to researchers’ understanding of the disease. The focus of this study is to find the biological differences between persons returning to good health after COVID-19 and persons who remained ill more than six months after infection and developed ME/CFS. Understanding these alterations in key pathways can lead to groundbreaking discoveries including new biomarkers, drug targets, and prevention and treatment strategies.
About Open Medicine Foundation
Established in 2012, Open Medicine Foundation leads the largest, concerted worldwide nonprofit effort to diagnose, treat, and prevent ME/CFS and related chronic, complex diseases such as Post Treatment Lyme Disease Syndrome, Fibromyalgia, and Post COVID. OMF adds urgency to the search for answers by driving transformational philanthropy into global research. We have raised over $28 Million from private donors and facilitated and funded the establishment of six prestigious ME/CFS Collaborative Research Centers around the world. To learn more, visit www.omf.ngo.
Heather Ah San
Development and Communications Manager